Really Good Antibodies

Antibodies to Factors and Regulators Over 2,000 Antibodies Targeting More Than 900 Proteins

bethyl.com Bethyl Laboratories, Inc. has been dedicated to supporting scientific discovery through its qualified antibody products and custom antibody services since its founding in 1972.

Every antibody that Bethyl sells has been manufactured to exacting standards at its sole location in Montgomery, Texas, and has been validated in-house by Bethyl’s team of scientists.

Antibodies are tested across a range of applications including western blot, immunoprecipitation, immunohistochemistry, immunocytochemistry, ChIP, proximity ligation assay and ELISA.

Currently, Bethyl’s portfolio consists of over 7,150 catalog products; offering close to 5,700 primary antibodies targeting over 2,700 proteins and 1,450 secondary antibodies raised against immunoglobulins from over 25 species.

With over 40 years of experience, Bethyl is also a leading provider of custom antibody production services. Bethyl offers complete packages from initial peptide synthesis to affinity purification of your specific antibody from an antigen-specific immunosorbent.

Because of its rigorous validation process and high standards, Bethyl does not sell every antibody it makes. Bethyl serves to advance science by concentrating its resources on developing qualified antibodies, including many to emerging and underserved protein targets.

Below is a sampling of some of Bethyl’s more than 2,000 antibodies targeting over 900 transcription factors and regulators. Please visit www.bethyl.com/category/pca_research_TRANSCRIPTION for a complete listing.

Detection of human phospho-RNA polymerase II (S5) in prostate carcinoma by Transcriptional Research Antibodies immunohistochemistry. Antibody: Rabbit anti- Phospho-RNA Polymerase II (S5), Cat# IHC-00387. Target Reactivities Applications # of Abs AATF / Che-1 Hu WB, IP, PLA 2 ABCA2 Hu WB, IP 2 ABL1 / cAbl Hu WB, IP, ICC, IF, IHC, PLA 3 ABT1 Hu WB, IP 2 ACTL6A / BAF53A Hu, Ms WB, IF, IHC, PLA 2 ADD1 / alpha-Adducin*** Hu WB, IP, IF, IHC 2 ADNP Hu WB, IF, IHC 2 ADRM1 Hu, Ms WB, IP, IF, IHC 3 AFF1 / AF4 Hu WB, IP, IF, IHC 2 AFF4 / MCEF Hu IP 2 AHCTF1 / ELYS Hu WB, IP 1 AIP Hu WB, IP 1 AKAP17A / SFRS17A Hu WB, IP 2 ALYREF / Aly Hu WB, IP, IF, IHC 2 ANKRD28 / PITK Hu WB, IP, IF, IHC 3 APBB2 Hu WB, IP 1 AR / Androgen *** Hu WB, IP, IF, IHC 2 ARHGAP35 / GRLF1 / Hu, Ms WB, IP, PLA 1 p190RhoGAP ARHGEF11 / PDZ-RhoGEF Hu WB, IP, IF, IHC 3 ARID1A / BAF250 Hu WB 2 ARID1B Hu WB, IP, IF, IHC 3 ARID2 Hu WB, IP, IF, IHC 3 ARID3A / DRIL1 Hu WB, IP, IF, IHC 2 ARID3B Hu WB, IP, IF, IHC 4 ARID4A Hu WB, IP 2 ARID4B Hu WB, IP, IF, IHC, PLA 3 ARID5B Hu WB, IP 2 Detection of Mouse Nanog by Western blot of ARNT Hu IP, IF, IHC 2 immunoprecipitates from F9 cell lysate. Antibodies: ARNTL / BMAL1 Hu, Ms WB, IP 1 Rabbit anti-Nanog Antibody, Cat# A300-397A. Nanog was also immunoprecipitated by Rabbit anti-Nanog Antibody, Cat# A300-398A. Cat# A300-397A was used for blotting immunoprecipitated Nanog. All antibodies are antigen affinity purified. *Phospho-specific available **mAb, pAb *** Indicates updated specs

We Make Every Antibody We Sell 800.338.9579 | bethyl.com Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Target Reactivities Applications # of Abs ARRB1 / beta- BRMS1L / MGC11296 Hu WB 2 Hu WB, IP, IF, IHC 1 Arrestin 1*** BTAF1 Hu WB, IP 4 ASCC1 Hu WB 1 BTF3 Hu WB, IP, IF, IHC 2 ASCC2 Hu, Ms WB, IP 2 C11orf30 / EMSY Hu WB, IP, IF, IHC 2 ASCC3 Hu, Ms WB, IP 2 C14orf169 / NO66 Hu WB, IP 2 ASH1L / ASH1*** Hu, Ms WB, IP, IF, IHC 2 C1QBP Hu, Ms WB, IP, IF, IHC 3 WB, IP, IF, IHC, ChIP-chip, ASH2L / ASH2 Hu, Ms 5 ChIP-PCR, PLA CALCOCO1 / CoCoA Hu, Ms WB, IP 2 ASXL2 Hu WB, IP 1 CALR / Calreticulin Hu, Ms WB, IP 2 ATF1*** Hu WB, IP, IF, IHC 3 CAMK4 Hu WB, IP, IF, IHC 4 ATF2 Hu WB, IP, PLA 2 CAMKK2 Hu WB, IP 1 ATF6*** Hu WB, IP, IF, IHC 2 CAND1 Hu, Ms WB, IP, IF, IHC 2 ATF7 Hu WB, IP 1 CAND2 / TIP120B Hu, Ms WB, IP 1 ATF7IP / MCAF Hu, Ms WB, IF, IHC 2 CAPN15 / Calpain-15 Hu WB, IP 2 ATMIN Hu WB, IP, PLA 2 CARHSP1 Hu WB, IP 1 ATN1 / Atrophin 1 Hu WB, IP 2 CARM1 Hu, Ms WB, IP, IF, IHC 4 ATRX Hu WB, IP, IF, IHC, PLA 2 CASP8AP2 / FLASH Hu, Ms WB, IP, IF, IHC 3 ATXN1 / Ataxin-1 Hu WB, IP 2 CBFA2T2 Hu WB, IP 1 ATXN2L Hu WB, IP 3 CBFA2T3 Hu WB, IP 1 ATXN7 / Ataxin-7 Hu WB 1 CBFB / CBF-beta Hu WB, IP 3 ATXN7L3 Hu WB 1 CBX2 Hu IP, ChIP-Seq 1 BACH1 Hu WB, IP 2 CBX3 Hu, Ms IP, IF, IHC, PLA 4 BANP / SMAR1 Hu, Ms, Rt WB, IP, IF, IHC 2 CBX4 / Pc2 Hu, Ms WB, IP, IF, IHC 2 BAZ1A / ACF1 Hu WB, IP 2 CBX6 Hu, Ms WB, IP, IF, IHC 3 BAZ1B / WSTF Hu, Ms WB, IP, ICC, IF, IHC 2 CBX7 Hu WB, IP, IF, IHC 2 BBX Hu WB, IP 2 CBX8 Hu WB, IP, ChIP-Seq 1 BCL10 Hu WB, IP 1 CC2D1A Hu, Ms WB, IP, ICC, IF, IHC 2 BCL11A Hu, Ms WB, IP 3 CCAR1 Hu, Ms WB, IP, IF, IHC 5 CCAR2 / DBC1 / p30 BCL11B Hu, Ms WB, IP, IF, IHC 4 Hu, Ms WB, IP, IF, IHC, PLA 5 DBC*** BCL2 / Bcl-2*** Hu IP, IF, IHC 1 CCNC / Cyclin C Hu WB, IP, IF, IHC 2 BCL9L Hu WB, IP 1 CCNE1 / Cyclin E1 Hu WB, IP, IF, IHC 2 BCLAF1 / BTF Hu, Ms WB, IP, IF, IHC 4 CCNH / Cyclin H Hu WB, IP 2 BCOR Hu WB, IP 2 CCNK / Cyclin K Hu WB, IF, IHC 1 BHLHE40 / DEC1 Hu WB, IP, IF, IHC 2 CCNL1 / Cyclin L1 Hu WB, IP, IF, IHC 3 BMI1 Hu, Ms WB, IP, IF, IHC, PLA 2 CCNL2 / Cyclin L2 Hu WB, IP 2 BPTF / FALZ Hu WB, IP, IF, IHC 2 CCNT1 / Cyclin T1*** Hu WB, IP, IF, IHC, PLA 4 BRCA1* Hu WB, IP, IF, IHC, PLA 12 CCNT2 / Cyclin T2 Hu WB, IP 1 BRCA2 Hu WB, IP 4 CD3EAP / PAF49 / CAST Hu WB, IP, ICC, IF, IHC 3 BRD1 Hu WB, IP 1 CDC40 Hu WB, IP 2 BRD2** Hu, Ms WB, IP, ICC, IF, IHC, PLA 5 CDC5L Hu WB, IP, IF, IHC 3 BRD3 Hu WB, IP, IF, IHC 3 CDC73 / Parafibromin Hu, Ms WB, IP, IF, IHC 3 BRD4 Hu, Ms WB, IP, IF, IHC, PLA 3 CDCA7L / JPO2 / RAM2 Hu WB, IP 1 BRD7 Hu WB, IF, IHC 2 CDK2 Hu, Ms WB, IP, IF, IHC, PLA 2 BRD8 Hu WB, IP, IF, IHC 3 CDK4*** NEW Hu WB, IP, IF, IHC 2 BRD9 Hu WB, IP 1 CDK5RAP2 Hu WB, IP, ICC, IF 2 BRF1 Hu, Ms WB, IP, IF, IHC, PLA 3 CDK7 Hu, Ms, Rt WB, IP, PLA 3 BRIP1 / BACH1 Hu WB, IP 2 CDK8 Hu WB, IP, IF, IHC 3

Cover: Detection of human HIF1 alpha in HeLa cells treated with cobalt chloride-200 mcM by immunocytochemistry. Antibody: Rabbit anti-HIF1 alpha, Cat# A300-286A. Target Reactivities Applications # of Abs CDK9*** Hu, Ms WB, IP, IF, IHC, PLA 2 Detection of human PML in prostate carcinoma by CDKN1C / p57kip2 Hu IP 2 immunohistochemistry. Antibody: Rabbit anti-PML CDKN2A / p14ARF / Antibody, Cat# A301-167A. Hu WB, IP, IF, IHC, PLA 4 p16INK4a CDX2 Hu WB, IP, IF, IHC 3 CEBPB / C/EBP beta Hu WB, IP, IF, IHC 2 CEBPZ / C/EBP zeta Hu WB, IP 4 CENPB Hu ICC, IF 1 CENPF / Mitosin Hu WB, IP, ICC, IF, IHC 5 CGGBP1 Hu, Ms WB, IP 2 CHAF1A / Caf1p150 Hu WB, IP, IF, IHC, PLA 4 CHAF1B / CAF-1 p60 Hu WB, IP, IF, IHC 3 WB, IP, ChIP-chip, ChIP- CHD1 Hu 2 Seq CHD3 Hu, Ms WB, IP, IF, IHC 3 CHD4 / Mi2 beta Hu, Ms WB, IP, ChIP-Seq, PLA 3 CHD6 Hu WB, IP 1 CHD7 Hu WB, IP, ChIP-Seq 2 CHD8 Hu, Ms WB, IP, IF, IHC 3 CHD9 / CReMM Hu WB, IP 1 CHEK2 / Chk2 Hu WB, IP, IF, IHC, PLA 4 CHTOP / SRAG Hu WB 2 CIC / Capicua Hu WB, IP 2 CIR1 Hu WB, IP 1 CLOCK Hu, Ms WB, IP 2 CNOT2 Hu IP, IF, IHC 2 CNOT3 Hu WB, IP, IF, IHC 2 COMMD3 Hu, Ms WB 1 COPS2 / CSN2 Hu, Ms WB, IF, IHC 3 COPS5 / CSN5 Hu, Ms WB, IF, IHC 2 CPSF1 / CPSF160 Hu, Ms WB, IP, IF, IHC, PLA 2 CPSF2 / CPSF100 Hu, Ms WB, IP, IF, IHC 4 CPSF3 / CPSF73 Hu, Ms WB, IP, IF, IHC 3 CPSF7 / CPSF59 Hu WB, IP, IF, IHC 3 CRABP2 Hu WB, IP, IF, IHC 3 CRAMP1L Hu WB, IP 3 CREB1 / CREB Hu, Ms WB, IP, IF, IHC, PLA 2 CREBBP / CBP Hu WB, IP, IF, IHC, PLA 3 Detection of Mouse DBC1/p30 in NIH3T3, CRK / Crk-II Hu WB 1 Renca, and TCMK-1 cell lysates by Western blot. CRTC1 / TORC1 Hu, Ms WB, IP, IF, IHC 3 Antibody: Goat anti-DBC1/p30 Antibody, Cat# A303-942A. CRTC2 / TORC2 Hu WB, IP, IF, IHC 3 CRTC3 / TORC3 Hu WB, IP, IF, IHC 2 CRY1 Hu WB, IP 1 CRY2 Hu WB, IP 1 CSDE1 / UNR Hu, Ms WB, IP 3 CSNK2A1 / CKII alpha Hu WB, IP, IF, IHC, PLA 4

All antibodies are antigen affinity purified. *Phospho-specific available **mAb, pAb *** Indicates updated specs

We Make Every Antibody We Sell Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Target Reactivities Applications # of Abs CSNK2A2 / CKII Hu WB, IP, IF, IHC, PLA 3 Hu WB, IP 1 alpha' Hu, Ms WB, IP, IF, IHC, PLA 3 CSNK2B / CKII beta Hu, Ms WB, IP, IF, IHC, PLA 3 E2F7 Hu WB, IP 2 CSTF1 / CSTF50 Hu WB, IP, IF, IHC 3 E2F8 Hu, Ms WB, IP 1 CSTF2 / CSTF64 Hu, Ms WB, IP, IF, IHC 3 Hu WB, IP 2 CSTF3 / CSTF77 Hu, Ms WB, IP, IF, IHC 4 EAF2 Hu IP, IF, IHC 3 CTBP1 Hu WB, IF, IHC, PLA 2 ECD / SGT1 Hu WB, IP 2 CTBP2 / Ribeye Hu, Ms WB, IP 2 EDF1 Hu WB, IP 1 CTCF Hu, Ms WB, IP, IF, IHC 4 EEF1D / EF-1 delta Hu WB, IP 3 CTDP1 / FCP1 Hu, Ms WB, IP 2 EGLN1 / PHD2 Hu WB 1 CTNNB1 / beta- Hu, Ms WB, IP, IF, IHC, PLA 4 EGR1 Hu, Ms WB, IP 2 catenin EHMT2 / G9A Hu WB, IF, IHC 2 CTNND1 Hu, Ms WB, IP, IF, IHC 4 ELF1 Hu WB, IF, IHC 2 CTR9*** Hu, Ms WB, IP, IF, IHC 2 ELF2 Hu WB, IP, IF, IHC 2 CXXC1 / CFP1 Hu, Ms WB, IP 2 ELF4 Hu WB, IP, IF, IHC 2 DACH1*** Hu WB, IP, IF, IHC 2 ELK1*** Hu WB, IP, IF, IHC, PLA 2 DAP / DAP1 Hu WB, IP 1 ELL Hu IP 2 DAPK3 / ZIPK NEW Hu, Ms WB, IP 2 ELL2 Hu, Ms WB, IP 1 DAXX Hu WB, PLA 2 ELMSAN1 / C14orf43 Hu WB, IP 1 DCP1A Hu WB, IP 3 ELP4 Hu WB, IP 1 DDX1 Hu WB, IP, IF, IHC 3 WB, IP, IF, IHC, ChIP-Seq, DDX17 Hu, Ms, Rt WB, IF, IHC 2 EP300 / p300 Hu 3 PLA DDX20 Hu WB, IP, IF, IHC 3 EPC1 Hu WB, IP, PLA 1 DDX3X / DDX3 Hu, Ms WB, IP, IF, IHC 4 EPN1 / Epsin 1 NEW Hu, Ms WB, IP 2 DDX5 Hu, Ms WB, IP, IF, IHC 3 ERBB2 Hu WB, IP, IF, IHC, PLA 4 DDX54 Hu WB, IP, IF, IHC 3 ERBB4 Hu WB, IP, PLA 2 DEAF1 Hu WB, IP 1 ERC1 Hu WB, IP 3 DEK Hu WB, IP, IF, IHC 3 ERCC2 / XPD Hu WB, IP 1 DENND4A Hu WB 1 ERCC3 Hu, Ms WB, IP, IF, IHC 3 DHX38 Hu, Ms WB, IP, IF, IHC 3 ERCC6 / CSB Hu WB, IP 3 DIDO1 / DATF1 Hu WB 1 ERF Hu, Ms IP, IF, IHC 3 DIP2B NEW Hu, Ms WB, IP 1 ESF1 / ABTAP Hu WB, IP 1 DMAP1 Hu WB, PLA 2 ESR1 / Estrogen Hu WB, IP, IF, IHC, PLA 6 DNAJC2 / MPP11 Hu, Ms WB, IP 2 Receptor Alpha* DNAJC8 / DjC8 Hu WB, IP 1 ESRRA / ERRalpha Hu IP 1 DNAJC9 / DjC9 Hu WB, IP 1 ETS1 Hu WB, IP 2 DNM2 / Dynamin ETV3 Hu WB, IP 2 Hu WB, IP, IF, IHC 2 2*** ETV6*** Hu WB, IP, IF, IHC 1 DNMT1 Hu WB, IP, PLA 3 EWSR1 / EWS Hu WB, IP, IF, IHC, PLA 4 DNMT3A NEW Hu, Ms WB, IF, IHC 1 EYA2 Hu WB, IP, IF, IHC 3 DOT1L Hu WB, IP, IF, IHC 3 EYA3 Hu WB, IP, IF, IHC 3 DPF2 Hu WB, IP 2

DPY30 NEW Hu IP 1 DR1 Hu WB 1 DVL2 / Dishevelled 2 Hu WB, IP 2 DYRK1B / MIRK Hu WB, IP 1

800.338.9579 | bethyl.com Detection of human FOXK2 by Western blot and immunoprecipitation. Samples: Whole cell lysate Target Reactivities Applications # of Abs from HeLa and 293T cells. Antibodies: Rabbit anti-FOXK2 Antibody, Cat# A301-730A used for EYA4 Hu WB, IP, IF, IHC 3 WB and IP. FOXK2 was also immunoprecipitated EZH2* *** NEW Hu, Ms WB, IP, IF, IHC 3 by Rabbit anti-FOXK2 Antibody, Cat# A301-729A, which recognizes a different epitope. FBXO38 Hu, Ms WB, IP, IF, IHC 1 FHL2 Hu, Ms WB, IP, IF, IHC 3 FIZ1 Hu, Ms WB, IP 2 FLII / Flightless-1 Hu WB, IP, IF, IHC 2 FLNA / Filamin A Hu, Ms WB, IP, IF, IHC, PLA 4 FOXC1*** Hu WB, IP, IF, IHC 2 FOXC2 Hu WB, IP 1 FOXJ3 Hu WB, IP 2 FOXK1 Hu, Ms WB, IP, IF, IHC 3 FOXK2 Hu WB, IP, IF, IHC 3 FOXM1 Hu WB, IP, IF, IHC 3 FOXN3 Hu WB, IP 1 FOXO1 / FOXO1a Hu WB, IP, PLA 1 FOXO3 / FOXO3a Hu, Ms WB, IP, IF, IHC, PLA 3 FOXO4 Hu WB 1 FOXP1 Hu, Ms WB, IP, IF, IHC 3 FOXP3 Hu WB, IP, IF, IHC 2 FOXP4 Hu WB, IP 1 FRYL Hu, Ms WB, IP 2 FUBP3 / FBP3 Hu, Ms WB, IP 2 GATA3*** Hu WB, IF, IHC 1 GATA4*** Hu WB, IP, IF, IHC 1 GATAD2A / p66alpha Hu, Ms WB, IP, IF, IHC 4 GATAD2B / p66beta Hu, Ms WB, IP, IF, IHC 4 GCFC2 / GCF Hu, Ms WB, IP 2 GLI3*** Hu WB, IP, IF, IHC 2 GLIS1 / Glis1 Hu WB 1 GMEB1 Hu, Ms WB, IP, IF, IHC 1 GMEB2 Hu WB, IP 2 GMNN / Geminin Hu WB, IP, IF, IHC 3 GRIP1 Hu WB, IP 2 GTF2A1 / TFIIA Hu, Ms IP, IF, IHC 1 GTF2B / TFIIB Hu IP, PLA 2 GTF2E1 / TFIIE-alpha Hu, Ms WB, IP, IF, IHC 2 GTF2F1 / RAP74 Hu IP, IF, IHC 2

GTF2H1*** Hu WB, IP, IF, IHC 1 Detection of human HIF1 alpha in asynchronous HeLa cells treated with cobalt chloride-200 mcM (left) or mock GTF2I / TFII-I Hu, Ms WB, IP, IF, IHC 6 treatment (right) by immunocytochemistry. Antibody: GTF2IRD1 / GTF2IRD / Rabbit anti-HIF1 alpha, Cat# A300-286A (upper Hu WB, IP, IF, IHC 3 TFII-IRD1 images) and A300-286A (lower images). Detection: Red-fluorescent Goat anti-Rabbit IgG (H+L), DyLight® GTF3A / TFIIIA Hu WB 1 594 Conjugated, Cat# A120-201D4. Counterstain: DAPI GTF3C1 / TFIIIC220 Hu WB, IP, IF, IHC, PLA 4 (blue) and fluorescent phalloidin (green). GTF3C2 / TFIIIC110 Hu WB, IP, IF, IHC 3 GTF3C3 / TFIIIC102 Hu, Ms WB, IP, IF, IHC 3 GTF3C4 / TFIIIC90 Hu WB, IP, IF, IHC 4

All antibodies are antigen affinity purified. *Phospho-specific available **mAb, pAb *** Indicates updated specs

We Make Every Antibody We Sell Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Target Reactivities Applications # of Abs GTF3C5 / TFIIIC63 Hu, Ms WB, IP, IF, IHC 2 IRF2BP2 Hu WB, IP 2 H2AFX / gamma- IRF3 Hu, Ms WB, IP, IF, IHC 4 Hu, Ms WB, ICC, IF, IHC, PLA 7 H2AX*** IRF5 Hu, Ms WB, IP 2 HCFC1 / HCF1 Hu, Ms WB, IP, PLA 2 IRF8 Ms WB, IP, ChIP-Seq 3 HCLS1 / HS1 Hu WB, IP 2 IVNS1ABP / NS1-BP Hu WB, IP 1 HDAC1 Hu, Ms WB, IP, IF, IHC, PLA 3 IWS1 NEW Hu, Ms WB, IP 1 HDAC2 Hu, Ms WB, IP, IF, IHC, ChIP-Seq 3 JMJD1C Hu WB, IF, IHC 2 HDAC3 Hu, Ms WB, IP, IF, IHC 2 JMY Hu WB, IP, IF, IHC 3 HDAC4 Hu WB, IP 2 JUN / c-Jun Hu, Ms WB, IP, IF, IHC, PLA 2 HDAC5 Hu WB, IP 2 JUNB Hu WB, IP, IF, IHC 2 HDAC6 Hu, Ms, Rt WB, IP, ChIP-Seq 2 JUP / Plakoglobin*** Hu WB, IP, IF, IHC 2 HDAC7 Hu, Ms WB, IF, IHC 3 KANK1 Hu WB, IP 1 HDGF*** Hu, Ms WB, IP, IF, IHC 3 KANK2 / SIP Hu WB, IP, IF, IHC 3 HDGFRP2 / HRP- Hu WB, IP 2 KAT2B / PCAF Hu WB, IP, ChIP-Seq 1 2 NEW KAT7 / HBO Hu, Ms WB, IF, IHC, PLA 3 HELLS Hu WB, IP 1 KAT8 / MOF / MYST1 Hu, Ms WB, IP, IF, IHC, PLA 4 HEXIM1*** Hu, Ms WB, IP, IF, IHC 3 WB, IP, IF, IHC, ChIP- HEXIM2 Hu IP 1 KDM1A / BHC110 / LSD1 Hu 4 Seq HIF1A / HIF1-alpha Hu, Ms WB, IP, ICC, IF, IHC, F, PLA 3 KDM2A / JHDM1A Hu WB, IP, IF, IHC 3 HIF1AN / FIH 1*** Hu IP, IF, IHC 1 KDM3A / JMJD1A / Hu WB, IP 2 HIST1H3A / Histone JHDM2A Hu, Ms WB, IP, ICC, IF, IHC, F, PLA 5 H3* KDM3B / JMJD1B Hu WB, IP, IF, IHC 2 HIST4H4 / Histone H4 Hu WB, IP, IF, IHC 3 WB, IP, IF, IHC, ChIP- KDM4A / JMJD2A Hu, Ms 3 HLTF / SMARCA3 Hu, Ms WB, IP 2 Seq HLX Hu WB, IP 1 KDM4B / JMJD2B Hu, Ms WB, IP 2 HMG20B / BRAF35 Hu WB, IP, PLA 1 KDM4C / JMJD2C Hu WB, IP 1 HMGB3 / HMG2a Hu, Ms WB, IP, IF, IHC 2 KDM5A / JARID1A / RBP2 Hu, Ms WB, IP, IF, IHC, PLA 2 HMGN1 Hu, Ms WB, IP, IF, IHC 3 KDM5B / JARID1B Hu, Ms WB, IP, IF, IHC 2

HMGN5 NEW Hu WB, IP 1 KDM5C / JARID1C Hu WB, IP, ChIP-Seq 2 HNF1A / HNF1- KDM5D / JARID1D / Hu WB, IP, IF, IHC 4 Hu WB, IP 2 alpha*** SMCY HNRNPK Hu, Ms WB, IP, IF, IHC 6 KHDRBS1 / SAM68 Hu, Ms WB, IP, IF, IHC 4 HNRNPL*** Hu, Ms WB, IP, IF, IHC 2 KHDRBS3 / SLM-2 Hu IP 2 HNRNPUL1 / E1B-AP5 Hu, Ms WB, IP, IF, IHC 3 KHSRP / KSRP Hu, Ms WB, IP, IF, IHC 3 HOXC10 Hu WB, IP 2 KLF10 / TIEG1 Hu WB 1 HSF1*** Hu WB, IP, IF, IHC 3 KLF12 Hu WB, IP 1 WB, IP, ChIP-chip, HSFX1 Hu IP 1 KMT2A / MLL1 Hu 4 ChIP-PCR, PLA HTATSF1 / Tat-SF1 Hu WB, IP, IF, IHC 2 WB, IP, ChIP-chip, KMT2B / TRX2 Hu 2 HTT / Huntingtin Hu WB, IP 2 ChIP-PCR, PLA IKBKAP / IKAP Hu WB, IP 2 L3MBTL2 Hu WB, IP, IF, IHC 2 IKBKB / IKK-beta Hu WB, IP, PLA 1 L3MBTL3 Hu WB, IP, IF, IHC 3 IKZF1 / Ikaros Hu WB, IP 1 LARP7 Hu, Ms WB, IP 2 IKZF2 / Helios Hu WB, IP 2 LEF1*** Hu WB, IP, IF, IHC 2 ILF2 / NF45*** Hu, Ms WB, IP, IF, IHC 1 LEO1 Hu, Ms WB, IP, IF, IHC 3 ILF3 / NF90 / Hu, Ms WB, IP, IF, IHC 5 LIMD1 Hu WB, IP 2 NF110*** LIN54 Hu WB, IP 2 IRAK1 Hu WB, IP 2 LPIN2 / Lipin2 Hu WB, IP 2 IRF1 Ms WB, IP 3 LPP Hu WB, IP, IF, IHC 2 IRF2 Hu, Ms WB, IP, ChIP-Seq 4 LRRFIP1 Hu WB, IP 3 IRF2BP1 Hu WB, IP 1 ChIP-chip scatter plot of anti-MLL1, Cat# A300- 374A, enriched DNA binding sites versus input reference DNA. A. 10 µg of A300-374A was used to immunoprecipitate MLL1 from K562 cells Target Reactivities Applications # of Abs according to Ren et al ( Dev. 2002 16: LSM11 Hu WB, IP 1 245-256). Immunoprecipitated DNA and reference DNA were amplified via ligation-mediated PCR Maf / c-Maf Ms WB, IF, IHC, ChIP-PCR 1 and the products labeled with fluorescent dUTPs. The labeled ChIP and reference DNA were pooled, MafA Ms WB, IF, IHC, ChIP-PCR 2 hybridized to a DNA microarray, and analyzed. MafB Ms IF, IHC 1 Data points below the +3 SD curve (red line) represent significantly enriched binding sites. B. MAML1 Hu WB, IP, IF, IHC 4 As a control, a similar experiment was performed MAML2 Hu, Ms WB, IP, IF, IHC 3 using normal rabbit IgG. Compared to the anti-MLL1 ChIP, normal rabbit IgG showed little MAML3 Hu, Ms WB, IP, IF, IHC 3 enrichment. MAP3K7 / TAK1 Hu WB, IP 2 MAPK1 / ERK2 Hu, Ms WB, IF, IHC, PLA 2 MAPK14 / p38 MAPK Hu, Ms WB, IP 2 MAPK3 / ERK1* Hu WB, IP, IF, IHC, PLA 4 MAX Hu WB, IP, IF, IHC 1 MAZ / SAF-1 Hu WB, IP, IF, IHC 2 MBD2 Hu, Ms WB, IP, IF, IHC 3 MBD3 Hu WB, IP, IF, IHC 3 MCM2* Hu, Ms, Bv, Xe WB, IP, IF, IHC, F, PLA 13 MCM3 Hu, Ms, Xe WB, IP, IF, IHC, PLA 5 MCM4*** Hu, Ms, Xe WB, IF, IHC, PLA 4 MCM5 Hu, Ms, Xe WB, IP, IF, IHC, PLA 2 MCM6 Hu, Ms WB, IF, IHC, PLA 4 MCM7 Hu, Ms WB, IP, PLA 4 MCM8 Hu WB, IP 1 MDM4 / HdmX* Hu WB, IP, IF, IHC, PLA 5 MECOM / EVI1 Hu IP 2 MED1 / CRSP1 / Hu, Ms WB, IP, IF, IHC, PLA 3 TRAP220*** MED12 Hu, Ms WB, IP, IF, IHC 2 MED13 / THRAP1 / Hu WB, IP 2 TRAP240 MED13L Hu WB, IP, IF, IHC 3 MED14 / CRSP2 / DRIP150 Hu WB, IP 1 MED15 Hu WB, IP, IF, IHC 3 MED16 Hu WB, IP 1 MED18 Hu, Ms WB, IP, IF, IHC 2 MED23 / CRSP3 Hu WB, IP 3 MED24 / TRAP100 Hu, Ms WB, IP 1 Detection of human KAP-1 in lung carcinoma (left) and ovarian carcinoma (right) by MED26 / CRSP7 Hu IP 2 immunohistochemistry. Antibody: Rabbit anti-KAP-1, MEF2A*** Hu, Ms WB, IF, IHC 1 Cat# A300-275A. MEF2D*** Hu, Ms WB, IP, IF, IHC 2 WB, IP, ICC, IF, IHC, ChIP- MEN1 / Menin** Hu, Ms 7 PCR, PLA

MEPCE NEW Hu, Ms WB, IP 2 MGA Hu IP 2 MIER3 Hu WB, IP 1 MKL1 Hu WB, IP, IF, IHC 3 MKL2 Hu, Ms WB, IP, IF, IHC 2

All antibodies are antigen affinity purified. *Phospho-specific available **mAb, pAb *** Indicates updated specs Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Target Reactivities Applications # of Abs MLF1 Hu WB, IP 1 NFATC4 / NFAT3 Hu, Ms WB, IP, IF, IHC 2 MLLT1 Hu WB, IP, IF, IHC 3 NFIB Hu WB, IP 2 MLLT3 / AF9 Hu WB, IP, IF, IHC 4 NFIC*** Hu, Ms WB, IP, IF, IHC 2 MLLT6 / AF17 Hu, Ms WB, IP 1 NFIL3 / E4BP4 Hu WB, IP 1 MLXIP / MondoA Hu WB, IP 1 NFKB1 / NF-kappaB1 Hu WB, IP, IF, IHC, PLA 3 MN1 Hu IP 1 NFKB2 / NF-kappaB2 Hu, Ms WB, IP, IF, IHC, PLA 3 MNT Hu WB, IP 2 NFKBIB / I kappa B-beta Hu WB, IP 1 MNX1 / HLXB9 Hu WB, IP 3 Nfkbiz / I kappa B-zeta Ms WB, IP 4 MOV10** Hu, Ms WB, IP, IHC, PLA 2 NFRKB Hu WB, IP, PLA 2 MPHOSPH8 / MPP8 Hu WB, IP 2 NFX1 Hu, Ms WB, IP 3 MTA1 Hu, Ms WB, IP, IF, IHC 3 NFXL1 Hu WB, IP 2 MTA2 Hu WB, IP, IF, IHC 2 NFYA / NF-YA Hu, Ms WB, IP, IF, IHC 3 MTA3 Hu WB, IP, IF, IHC 2 NFYC / NF-YC Hu, Ms WB, IP, IF, IHC 3 MTDH / AEG1 Hu, Ms WB, IP 3 NIPBL Hu WB, IP 2 MTPAP / PAPD1 Hu WB, IP 1 NKRF / NRF Hu WB, IP 1 MYB / c-Myb*** Hu, Ms WB, IP, IF, IHC 5 NMI Hu WB, IP, IF, IHC 3

MYBBP1A Hu WB, IP, IF, IHC 3 NOC2L / NIR NEW Hu WB 1 MYBL2 / B-Myb Hu IP, IF, IHC 4 NOLC1 / NOPP140 Hu WB, IP, IF, IHC 3 / c-myc Tag WB, IP, ICC, IF, ELISA, PLA 17 NONO Hu, Ms, Rt WB, IP, IF, IHC, PLA 3 MYCBP2 / PAM Hu WB, IP 2 NOTCH1 Hu WB, IP, IF, IHC, PLA 3 MYEF2 Hu WB, IP 2 NOTCH2 Hu WB, IP, IF, IHC 3 MYNN / Myoneurin Hu WB 1 NPAT Hu WB, IP, IF, IHC 2 MYSM1 Hu WB, IP 2 NPM1 Hu, Ms WB, IP, IF, IHC, PLA 4 NAA15 / NARG1 Hu, Ms WB, IP, IF, IHC 2 NR2C1 / TR2 Hu, Ms WB, IP 2 NAB1 Hu, Ms WB, IP 2 NR2F6 / EAR2 Hu WB, IP 2 NAB2 Hu WB, IP 1 NR3C1 / GR*** Hu, Ms WB, IP, IF, IHC 4 Nanog Ms WB, IP, IF, IHC 3 NRBF2 Hu, Ms WB, IP, IF, IHC 3

NBN / NBS1 Hu, Ms WB, IP, IF, IHC, PLA 5 NRG3 / Neogenin NEW Hu, Ms WB, IP 1 NCBP1 / CBP80 Hu, Ms WB, IP, IF, IHC 3 NSD1 Hu IF, IHC 1 NCBP2 Hu, Ms WB, IP, IF, IHC 3 NUFIP1 Hu WB, IP 2 NCOA1 / SRC1 Hu WB, IP, PLA 2 ORC2 Hu WB, IP, IF, IHC, PLA 2 NCOA2 / SRC2 Hu, Ms WB, IP, IF, IHC, PLA 5 PA2G4 / EBP1*** Hu, Ms WB, IP, IF, IHC 2 NCOA3 / SRC3 Hu WB, IP, PLA 2 PABPN1*** Hu, Ms WB, IP, IF, IHC 2 NCOA4 / ARA70 Hu WB, IP, IF, IHC 3 PAF1 Hu, Ms, Rt WB, IP, IF, IHC 3 NCOA5 / CIA Hu, Ms WB, IP, IF, IHC 3 PAGR1 / PA1 Hu WB, IP, IF, IHC 3 NCOA6 / ASC2 Hu WB, IP, IF, IHC 3 PAPOLA Hu WB, IP 3 NCOR1 / NCoR Hu, Ms WB, IP, ChIP-Seq, PLA 2 PAPOLG / PAP-gamma Hu, Ms WB, IP 2 NCOR2 / SMRT Hu WB, IP, PLA 2 PARP1 Hu WB, IF, IHC, PLA 3 NEDD4L Hu, Ms WB, IP, IF, IHC 4 PARP10 Hu, Ms WB, IP, IF, IHC 2 NELFA Hu WB, IP, IF, IHC 2 PASK / PASKIN Hu WB, IP 2 NELFB / COBRA1 Hu WB, IP, IF, IHC 3 PAWR / Par4 Hu WB, IP 2 NELFE Hu WB, IP, IF, IHC 3 NF1 Hu, Ms WB, IP 1 NFATC1 Hu WB, IP 1 NFATC2 / NFAT1 Hu WB, IP 1 NFATC3 Hu WB, IP 3

800.338.9579 | bethyl.com Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Target Reactivities Applications # of Abs

PAXBP1 / GCFC1 Hu WB, IP 3 PPARG / PPAR-gamma NEW Hu, Ms WB, IP 2 PAXIP1 / PTIP Hu WB, IP 2 PPARGC1A / PGC-1 Hu IF, IHC 1 PBRM1 / PB1 / PPARGC1B / PGC-1beta Hu WB, IP 2 Hu WB, IP 2 BAF180 PPP1R10 / PNUTS Hu WB, IP, IF, IHC 4 PBXIP1 / HPIP Hu, Ms WB, IP, IF, IHC 3 PPP1R13L / iASPP Hu WB, IP 2 PCF11 Hu WB, IP 2 PPP2R1A Hu, Ms WB, IP 2 PCGF2 / Mel-18 Hu WB 1 PPP5C Hu, Ms WB, IP, IF, IHC, PLA 2 PDCD11 Hu WB, IP 2 PQBP1 Hu, Ms WB, IP, IF, IHC 2 PDCD4 Hu WB, IP 2 PRDM10 Hu, Ms WB, IP 1 PDLIM1 / CLP36 Hu IP 2 PRKAA1 / AMPK alpha 1 Hu, Ms, Rt, Bv WB, IP, IF, IHC 3 PDLIM7 / LMP1 Hu WB, IP 2 PRKAA2 / AMPK alpha 2 Hu, Ms, Rt, Bv WB, IP 2 PDPK1 / PDK1 Hu, Ms WB, IP 1 PRKAR1A Hu WB, IP 2 PELP1 / MNAR Hu, Ms WB, IP, IF, IHC 3 PRKDC / DNA-PKcs*** Hu WB, IP, IF, IHC, PLA 6 PER2 Hu WB 1 PRMT5 Hu, Ms WB, IP, IF, IHC 3 PEX14 Hu WB, IP 2 PRMT6 Hu, Ms WB, IP, IF, IHC 3 PFDN1 / Prefoldin 1 Hu WB, IP 1 PRPF6 / PRP6 Hu, Ms WB, IP, IF, IHC 2 PFDN5 / MM-1 Hu, Ms WB 1 PSIP1 / LEDGF / p75 Hu, Ms WB, IP, IF, IHC 2 PGR / Progesterone Hu WB, IP 1 Receptor PSMC3 / TBP1*** Hu, Ms WB, IP, IF, IHC 2 PHB / Prohibitin Hu WB, IF, IHC 2 PSMC5 / TRIP1 / SUG1 Hu, Ms WB, IP, IF, IHC 3 PHB2 / REA Hu, Ms WB, IP, IF, IHC 4 PSPC1 / PSP1 Hu, Ms WB, IP 2 PHF12 / PF1 Hu, Ms WB, IP 2 PTRF Hu, Ms WB, IP 3 PHF17 / Jade-1 Hu, Ms WB, IP 1 PUF60 Hu, Ms WB, IP, IF, IHC 3 PHF19 Hu, Ms WB, IP 2 PURA / Pur-alpha Hu, Ms WB, IP 2 PHF2 Hu WB 1 PURB / Pur-beta Hu IP 2 PHF20 Hu WB, IP, IF, IHC 3 PUS1 Hu WB, IP, IF, IHC 2 PHF21A Hu WB, IP 1 PWP1 Hu WB, IP 2 PHF6 Hu, Ms WB, IP, IF, IHC 4 RAD54L2 / ARIP4 Hu WB, IP, IF, IHC 2 WB, IP, IF, IHC, ChIP-Seq, RAI1 Hu WB, IP, IF, IHC 1 PHF8 Hu, Ms 3 PLA RAN NEW Hu, Ms WB, IP, IF, IHC 2 PIM1 Hu WB, IP, PLA 1 RB1 Hu WB, IP 2 PITX1 Hu WB, IP 1 RB1CC1 / FIP200 Hu, Ms WB, IP 2 PKN2 Hu WB, IP 2 RBBP4 Hu, Ms WB, IP, IF, IHC, PLA 2 PLRG1 Hu, Ms WB, IP, IF, IHC 2 WB, IP, ICC, IF, IHC, PML Hu WB, IP, IF, IHC, PLA 3 RBBP5 Hu, Ms ChIP-chip, ChIP-PCR, 2 ChIP-Seq PNN / Pinin Hu, Ms WB, IP 1 RBBP7 Hu, Ms WB, IP, IF, IHC, PLA 3 POGK Hu WB, IP 1 RBBP8 / CtIP Hu, Ms WB, IP, PLA 2 POGZ Hu, Ms WB, IP, IF, IHC 3 RBFOX2 / RBM9 Hu, Ms, Rt WB, IP, IF, IHC 2 POLR2A / RNA WB, IP, IF, IHC, ChIP-PCR, RBM14 / CoAA Hu WB, IP, IF, IHC 3 Polymerase II* *** Hu, Ms 9 PLA NEW RBM15 Hu WB, IP 1 POLR2B / Rpb2 Hu WB, IP 2 RBM39 / Caper Hu WB, IP, IF, IHC 3 POLR2C / RPB3*** Hu, Ms WB, IP, IF, IHC 1 RBM8A / RBM8a Hu, Ms WB 1 POLR3B / RPC2 Hu WB, IP, IF, IHC 2 RCOR1 / CoREST Hu WB, IF, IHC, PLA 2 POLR3C / RPC3 Hu, Ms WB, IP 2 RCOR3 Hu, Ms WB, IP, ICC, IF, IHC 3 POLR3D Hu WB, IP, IF, IHC 3 REL / c-Rel Hu WB, IP, PLA 2 POLR3E Hu WB, IP 2 RELA* Hu, Ms WB, IP, IF, IHC, PLA 9 POU2F1 / OCT1 Hu, Ms IP, IF, IHC 3 RELB Hu, Ms WB, IP, PLA 2 POU3F2 / Brn-2 Hu WB 1 REST Hu WB, IP, IF, IHC 3

Pou5f1 / Oct 4 NEW Ms WB, IP 2 Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Target Reactivities Applications # of Abs RFC1 Hu WB, IP, PLA 2 SIRT2 Hu WB, IP 2 RFX1*** Hu, Ms WB, IP, IF, IHC 3 SIX4 Hu WB, IP 2 RFX5 Hu WB, IP 2 SKAP1 Hu WB 1 RFX7 Hu WB, IP 2 SKI / c-Ski Hu WB, IP 2 RFXANK Hu WB, IP 2 SLBP Hu WB, IP 1 RFXAP Hu WB, IP 2 SLTM Hu WB, IP, IF, IHC 2 RING1* Hu WB, IP, IF, IHC 1 SMARCA1 / SNF2L Hu IP, IF, IHC 2

RIPK3 / RIP3 NEW Hu WB, IP 1 SMARCA2 / BRM Hu WB, IP 6 RLF Hu WB, IP 1 SMARCA4 / BRG1*** Hu, Ms WB, IP, IF, IHC, PLA 4 RNF19A / Dorfin Hu IP 1 SMARCA5 / SNF2h / ISWI Hu WB, IP 2 RNF2 Hu, Ms WB, IP, IF, IHC, ChIP-Seq 2 SMARCAD1 / ETL1 Hu WB, IP 2 RNF20 Hu WB, IP, IF, IHC 3 SMARCAL1 Hu WB, IP 1 RNF25 Hu WB, IP 1 SMARCB1 / SNF5 Hu, Ms WB, IP, IF, IHC 2 RNGTT Hu, Ms WB, IP, IF, IHC 2 SMARCC1 / BAF155 Hu, Ms WB, IP 3 RPL6*** Hu WB, IF, IHC 3 SMARCC2 / BAF170 Hu, Ms WB, IP, IF, IHC 3 RPL7 Hu, Ms WB, IP, IF, IHC 3 SMARCD1 / BAF60a Hu WB, IP 2 RPRD1B Hu, Ms WB, IP 1 SMARCD2 / BAF60b Hu WB 1

RRAGC / RagC NEW Hu, Ms WB, IP 3 SMARCE1 / BAF57 Hu, Ms WB, IP, IF, IHC 2 RREB1 Hu WB, IP 2 SMYD2 Hu, Ms WB, IP 1 RRN3 / TIF-IA Hu WB, IP 1 SNAPC4 / SNAP190 Hu WB, IP 1

RRP8 NEW Hu WB, IP 2 SND1 Hu, Ms WB, IP, IF, IHC 1 RTF1 Hu, Ms WB, IP, IF, IHC 4 SNIP1 Hu WB, IP 1 RUNX1T1 / ETO Hu WB, IP 1 SNRPD3 / Sm-D3*** Hu, Ms WB, IP, IF, IHC 2 RUVBL2 Hu, Ms WB, IP, IF, IHC, PLA 3 SNW1 / NCOA62 Hu, Ms WB, IP, IF, IHC 3 RYBP Hu IP 1 SOD2 / MnSOD Rt WB 2 SAFB / SAFB1 Hu, Ms WB, IP, IF, IHC 3 SOX13 Hu WB, IP 1 SAFB2 Hu WB, IP, IF, IHC 4 Hu WB, IP 3 SALL2 Hu WB, IP 1 SOX6 Hu WB, IP 1 SAP130 Hu WB, IP, IF, IHC 3 SP1 Hu, Ms WB, IP, IF, IHC, PLA 4 SAP30 Hu, Ms WB, IP 1 SP3 Hu, Ms WB, IP, IF, IHC 3 SAP30BP Hu, Ms WB, IP 2 SPEN / SHARP Hu WB, IP 2 SQSTM1 / SARNP / CIP29 Hu WB, IP 2 Hu, Ms WB, IP, IF, IHC 3 Sequestosome-1 SATB2 Hu WB, IP 2 SRA1 / SRA Hu WB, IP, IF, IHC 3 SCML2 Hu WB, IP 2 SREBF2 / SREBP2 Hu WB, IP 1 SCYL1 / TEIF Hu, Ms WB, IP 2 SRF*** Hu WB, IP, IF, IHC 2 WB, IP, IF, IHC, ChIP-chip, SETD1A / hSET1 Hu, Ms 4 ChIP-PCR SRFBP1 / p49 / STRAP Hu WB, IP 1

SETD1B / hSET1B Hu IP, IF, IHC 3 SRRT / ARS2 NEW Hu, Ms WB, IP 2 SETD3 Hu, Ms WB, IP 2 SRSF1 / ASF Hu WB, IP 2 SETD7 / SET7 Hu, Ms WB, IP, IF, IHC 2 SRSF10 / FUSIP1 Hu WB, IF, IHC 2 SETDB1 Hu WB, IP, PLA 1 SRSF4 / SRp75*** Hu WB, IP, IF, IHC 2 SF1*** Hu, Ms WB, IP, IF, IHC 2 SRSF6 / SRp55*** Hu, Ms WB, IP, IF, IHC 1 SFMBT1 Hu WB, IP 1 SRSF7 Hu, Ms WB, IP, IF, IHC 2 SFN / 14-3-3 Sigma Hu WB, IP, IF, IHC, PLA 2 SSB / SS-B Hu, Ms WB, IP, IF, IHC 2 SFPQ / PSF Hu, Ms WB, IP, IF, IHC, PLA 4 SSRP1 Hu WB, IP, IF, IHC 2 SFSWAP / SFRS8 / STAT1 Hu, Ms WB, IP 2 Hu WB, IP, IF, IHC 2 SWAP STAT2*** Hu WB, IP, IF, IHC 3 SIN3A Hu, Ms WB, IP, IF, IHC, PLA 4 STAT3 Hu, Ms WB, IP, PLA 2 SIRT1 Hu WB, IP, PLA 2 STAT5A*** Hu WB, IP, IF, IHC 1 Detection of human Menin by Western blot of immunoprecipitates from HeLa cell lysate. Antibodies: Rabbit anti-Menin Antibody, Cat# A300-105A was used for IP. Menin was also Target Reactivities Applications # of Abs immunoprecipitated by Rabbit anti-Menin STAT5B*** Hu WB, IP, IF, IHC 1 Antibody, Cat# A300-115A. Cat# A300-105A was used for blotting immunoprecipitated Menin. STAT6 Hu, Ms WB, IP, IF, IHC 2 STK4 / MST1 Hu, Ms WB, IP, IF, IHC 2 SUB1 / PC4 Hu, Ms WB, IP, IF, IHC 3 SUDS3 / SDS3 Hu, Ms WB, IP, PLA 2 SUFU Hu, Ms WB, IP 2 SUPT16H / Spt16 Hu WB 1 SUPT5H Hu, Ms WB, IP, IF, IHC 3 SUPT6H Hu, Ms WB, IP, IF, IHC 4 SUPT7L Hu, Ms WB, IP, IF, IHC 1 SUV39H1 Hu WB, IP, IF, IHC 3 SUZ12 Hu, Ms WB, IP 1 TAF1*** Hu WB, IP, IF, IHC 2 TAF15 / TAFII68 Hu WB, IP, IF, IHC 4 TAF1C Hu WB, IP 2 TAF2 Hu IP 2 TAF3 Hu WB, IP 2 TAF5*** Hu WB, IP, IF, IHC, PLA 3 TAF6 Hu WB, IP, IF, IHC 3 TAF8 Hu IP 1 TAF9B Hu WB, IP 1 TARBP1 Hu WB, IP 1 TARDBP / TDP43*** Hu, Ms WB, IP, IF, IHC 2 TBL1XR1 / TBLR1 Hu WB, IP, IF, IHC 2 TBP Hu WB 1 TBX3 Hu WB, IP 1 TCEA1 / TFIIS Hu, Ms WB, IP, IF, IHC 3 TCEB2*** Hu, Ms WB, IP, IF, IHC 1 TCEB3 Hu WB, IP, IF, IHC 4 TCERG1 / CA150 Hu, Ms WB, IF, IHC 2 TCF12 Hu WB, IP, IF, IHC 3 TCF25 / Nulp1 Hu, Ms WB, IP 2 TCF3 / E2A* Hu WB 1

TDG* NEW Hu WB, IP, IF, IHC 1 TDP2 Hu WB, IP, IF, IHC 1 TDRD3 Hu, Ms WB, IP, IF, IHC 3 TERF2 / TRF2 Hu WB, IP, PLA 1 TERF2IP / RAP1*** Hu WB, IP, IF, IHC 4 TFAM*** Hu WB, IP, IF, IHC 2 TFAP4 / AP4 Hu WB, IP 2 Detection of human phospho-KAP-1 (S824) by Western blot of immunoprecipitates from Whole cell TFE3 Hu WB, IP 2 lysate from asynchronous HeLa cells that were either mock treated or treated with Etoposide. Antibodies: TFEB Hu, Ms WB, IP, IF, IHC 2 KAP-1 was immunoprecipitated using Rabbit anti- TGS1 / PIMT Hu WB, IP, IF, IHC 2 KAP-1 Antibody, Cat# A300-274A. Rabbit anti- phospho KAP-1 (S824) Antibody, Cat# A300-767A THAP11 / Ronin Hu, Ms WB, IP 2 was used for blotting immunoprecipitated phospho- THAP7 Hu WB 1 KAP-1 (S824). To examine total KAP-1, the blot was stripped and then blotted with Rabbit anti-KAP-1 THOC1 Hu WB, IP, IF, IHC 2 Antibody, Cat# A300-274A. THRAP3 / TRAP150 Hu WB, IP, IF, IHC 3 All antibodies are antigen affinity purified. *Phospho-specific available **mAb, pAb *** Indicates updated specs We Make Every Antibody We Sell Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Target Reactivities Applications # of Abs TIAL1 / TIAR Hu WB, IP 2 UBTF / UBF Hu IP 1 TIMELESS / Timeless Hu, Ms WB, IP, IF, IHC, PLA 3 UBXN7 / UBXD7 Hu, Ms WB, IP 1 TLE1*** Hu WB, IP, IF, IHC 1 UCHL5 / UCH37 Hu, Ms WB, IP 3 TLE2 Hu WB, IP 1 UHRF1 / NP95 Hu WB, IP, IF, IHC 2 TMF1 Hu WB, IP 2 UIMC1 / RAP80 Hu WB, IP, IF, IHC 3 TMX1 Hu WB 1 UPF3B Hu WB, IP 2 TOE1 Hu WB, IP 2 URI1 / RMP Hu WB, IP 2 TONSL / NFKBIL2 Hu WB 1 USF2*** Hu, Ms WB, IP, IF, IHC 3 TOP1 Hu, Ms WB, IP 2 USP16 Hu WB, IP 2 TOPORS Hu WB, IP, IF, IHC 2 USP7*** Hu, Ms, Rt WB, IP, IF, IHC, PLA 4 TP53 / Hu WB, IP, IF, IHC, F, PLA 4 USP9X Hu, Ms WB, IP 2 TP53BP1 / 53BP1* *** Hu, Ms WB, IP, IF, IHC, F, PLA 6 VDR Hu IP 2 TP73 / Hu WB, IP, IF, IHC, PLA 2 VIPAS39 / VIPAR Hu, Ms WB, IP 1 TRAF6 Hu WB 1 VPRBP Hu, Ms WB, IP 2 TRERF1 / TReP-132 Hu WB, IP, IF, IHC 3 VPS72 / YL1 Hu WB, IP, PLA 1 TRIM16 / EBBP Hu, Ms WB, IP 2 WDHD1 / AND-1 Hu WB, IP 2 TRIM24 / TIF1 Alpha Hu, Ms WB, IP, IF, IHC, PLA 3 WDR5*** Hu, Ms, Rt WB, IP, IF, IHC, PLA 3 TRIM25 Hu WB, IP 3 WDR77 / MEP50 Hu, Ms WB, IP, IF, IHC 3 TRIM28 / KAP-1* *** Hu, Ms WB, IP, ICC, IF, IHC, PLA 9 WHSC1 / NSD2*** Hu WB, IP, IF, IHC 2 TRIM29 / ATDC Hu IP 2 WWP2 Hu, Ms WB, IP 2 TRIM33 / TIF1gamma Hu, Ms WB, IP, IF, IHC 4 XAB2 Hu WB, IP 2 TRIP11 / TRIP230 Hu WB, IP 2 XRCC5 / Ku80 Hu WB, IP, IF, IHC, PLA 3 TRIP13 Hu WB, IP 3 XRCC6 / Ku70 Hu WB, IP, IF, IHC, PLA 4 TRIP4 / ASC-1 Hu, Ms WB, IP 2 XRN2 Hu, Ms WB, IP, IF, IHC 4 TRIP6 Hu WB, IP 3 YAF2 Hu WB 1 TROVE2 / Ro60 Hu WB, IP 2 YAP1 Hu WB, IP, IF, IHC 3 TRPS1*** Hu WB, IP, IF, IHC 2 YBX1 / YB1*** Hu, Ms WB, IP, IF, IHC 2 TRRAP Hu, Ms WB, IP, PLA 2 YBX3 / ZONAB Hu WB, IP 1 TSC22D1*** Hu WB, IP, IF, IHC 2 YLPM1 / ZAP3 Hu WB, IP 1 TSC22D2 Hu IP 1 YWHAQ / 14-3-3 theta*** Hu, Ms WB, IP, IF, IHC 2 TSC22D4 Hu WB 1 YY1 Hu, Ms WB, IP, IF, IHC, PLA 2 TSG101 Hu, Ms WB, PLA 2 ZBTB1 Hu, Ms WB 1 TSPYL2 / DENTT Hu WB, IP 2 ZBTB10 Hu WB, IP 2 TTF1 Hu WB 1 ZBTB11 Hu WB, IP 2 TTF2 Hu WB, IP 1 ZBTB2 Hu, Ms WB, IP 2

TTLL5 / STAMP NEW Hu WB, IP 2 ZBTB21 / ZNF295 Hu WB, IP, IF, IHC 3 TWISTNB / RPA43 Hu WB 1 ZBTB3 Hu WB, IP 1 TXLNG / gamma- ZBTB33 / Kaiso Hu WB, IP 2 Hu, Ms WB, IP 3 Taxilin ZBTB38 Hu WB, IP 1 TXNIP*** Hu IP, IF, IHC 1 ZBTB40 Hu WB, IP, IF, IHC 2 U2AF1 / U2AF35 Hu, Ms WB, IP, IF, IHC 3 ZBTB44 Hu WB, IP 2 U2AF2 / U2AF65*** Hu WB, IP, IF, IHC 3 ZBTB5 Hu WB, IP 3 UBA2 / SAE2 Hu, Ms WB, IP, IF, IHC 2 ZBTB7A / ZBTB7 / FBI-1 Hu, Ms WB, IP, IF, IHC 3 UBA52 / Ubiquitin Hu, Ms, Bv WB, IF, IHC 2 ZBTB7B Hu WB, IP 1 UBE2L3 / UBCH7 Hu, Ms WB, IP, IF, IHC 2 ZBTB8A Hu WB, IP 1 UBE3A / E6AP Hu, Ms WB, IP 2 ZBTB9 Hu WB, IP 2 UBN1 / Ubinuclein-1 Hu WB 1 ZC3H3 Hu WB, IP 1 UBR5 / EDD1*** Hu, Ms WB, IP, IF, IHC 4 ZC3H8 Hu WB, IP 2 Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Target Reactivities Applications # of Abs ZEB1 Hu, Ms WB, IP, IF, IHC 3 ZNF655 / VIK Hu WB, IP 1 ZEB2 / SIP1 Hu, Ms WB, IP, IF, IHC 3 ZNF687 Hu, Ms WB, IP 2 ZFP64 Hu, Ms WB, IP 1 ZNF703 Hu WB, IP 2 ZFPM1 / FOG1 Hu WB, IP, IF, IHC 2 ZNF711 Hu WB 1 ZHX1 Hu WB, IF, IHC 2 ZNF768 Hu WB, IP, IF, IHC 3 ZHX2 Hu IP 2 ZNF777 Hu WB, IP 1 ZHX3 Hu WB, IP, IF, IHC 3 ZNF787 Hu, Ms WB, IP 2 ZKSCAN1 Hu WB, IP 2 ZNF8 Hu WB, IP, PLA 2 ZKSCAN2 Hu WB 1 ZNF800 Hu WB, IP 1 ZKSCAN8 / ZNF192 Hu WB 1 ZNHIT3 / TRIP3 Hu WB, IP 2 ZRANB2 / ZMYM2 / ZNF198 Hu, Ms WB, IP, IF, IHC 4 Hu WB, IP 2 ZNF265 / ZIS ZNF142 Hu WB 1 ZSCAN29 Hu WB, IP 2 ZNF148 / ZBP89 Hu, Ms WB, IP 2 ZXDA Hu WB 1 ZNF184 Hu WB, IP 2 ZZZ3 Hu WB, IP 1 ZNF217 Hu WB, IP 2 ZNF24 Hu, Ms WB, IP 2 ZNF276 Hu WB 1 ZNF280D Hu WB, IP 2 ZNF281 Hu WB, IP 1 ZNF292 Hu IP 1 ZNF316 Hu WB, IP 2 ZNF318 / TZF Hu WB, IP, IF, IHC 3 ZNF324 Hu WB 1 ZNF326 Hu WB, IP, IF, IHC 2 ZNF335 / NIF1 Hu, Ms WB, IP, IF, IHC, PLA 3 ZNF358 Hu, Ms WB, IP 2 ZNF384 / CIZ Hu WB, IP 2

ZNF407 NEW Hu, Ms WB, IP 2 ZNF423 / OAZ Hu WB, IP 2 ZNF444 Hu WB, IP 2 ZNF462 Hu WB, IP 1 ZNF503 Hu, Ms WB, IP 3 ZNF507 Hu WB, IP 1 ZNF512B Hu WB 3 Detection of human MCM in breast carcinoma by ZNF516 Hu WB, IP 1 immunofluorescence. Antibody: Rabbit anti-MCM IHC Antibody, Cat# IHC-00009. ZNF518A Hu WB, IP 2 ZNF532 Hu WB 1 ZNF574 Hu WB, IP 1 ZNF579 Hu WB, IP 1 ZNF592 Hu WB, IP, IF, IHC 3 ZNF622 / ZPR9 Hu, Ms WB, IP 3 ZNF638 / NP220 Hu WB, IP 2 ZNF639 Hu WB, IP 2 ZNF644 Hu WB, IP 1 ZNF652 Hu, Ms WB, IP 1

ZNF654 NEW Hu WB, IP 1

All antibodies are antigen affinity purified. *Phospho-specific available **mAb, pAb *** Indicates updated specs Really Good Antibodies

Transcriptional Research Antibodies Transcriptional Research Antibodies

Target Reactivities Applications # of Abs Select Journal Citations ZNF655 / VIK Hu WB, IP 1 Target Title Journal ZNF687 Hu, Ms WB, IP 2 ASH2L Interaction of MYC with the trithorax protein ASH2L promotes transcription Nucleic Acids Res. 2014 Apr 29. ZNF703 Hu WB, IP 2 by regulating H3K27 modification. ZNF711 Hu WB 1 BCLAF1 Involvement of bcl-2-associated 1 in the differentiation of J Neurosci. 2014 Jan 22;34(4):1530- ZNF768 Hu WB, IP, IF, IHC 3 early-born retinal cells. 41.

ZNF777 Hu WB, IP 1 BMI1 TRIM37 is a new histone H2A ubiquitin ligase and breast oncoprotein. Nature. 2014 Dec 4;516(7529):116- ZNF787 Hu, Ms WB, IP 2 20. ZNF8 Hu WB, IP, PLA 2 BRCA1 -Dependent Role of the Fragile X Mental Retardation Protein FMRP in the Cell. 2014 May 8;157(4):869-81. DNA Damage Response. ZNF800 Hu WB, IP 1 BRD4 Therapeutic targeting of BET bromodomain proteins in castration-resistant Nature. 2014 Jun 12;510(7504):278- ZNHIT3 / TRIP3 Hu WB, IP 2 prostate cancer. 82. ZRANB2 / Hu WB, IP 2 ZNF265 / ZIS CCAR2 DBIRD complex integrates alternative mRNA splicing with RNA polymerase II Nature. 2012 Mar 25;484(7394):386- transcript elongation. 9. ZSCAN29 Hu WB, IP 2 CDK5RAP2 Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM Nat Cell Biol. 2015 Jan;17(1):31-43. ZXDA Hu WB 1 to allow centriole separation, disengagement and licensing. ZZZ3 Hu WB, IP 1 CHD8 BRAF Oncoprotein Functions through the Transcriptional Repressor MAFG to Mol Cell. 2014 Sep 18;55(6):904-15. Mediate the CpG Island Methylator Phenotype.

DDX1 Analysis of orthologous groups reveals archease and DDX1 as tRNA splicing Nature. 2014 May 25. factors.

H2AFX Interchromosomal Homology Searches Drive Directional ALT Telomere Movement Cell. 2014 Sep 25;159(1):108-21. and Synapsis.

HEXIM1 RNA helicase DDX21 coordinates transcription and ribosomal RNA processing. Nature. 2014 Nov 24.

KDM1A Reconstructing and Reprogramming the Tumor-Propagating Potential of Cell. 2014 Apr 9. pii: S0092- Glioblastoma Stem-like Cells. 8674(14)00229-3.

MED12 Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding Cell. 2014 Jul 31;158(3):593-606. RNAs in Acute Leukemia.

Nanog Master transcription factors and mediator establish super-enhancers at key cell Cell. 2013 Apr 11;153(2):307-19. identity genes.

NCOA4 Quantitative proteomics identifies NCOA4 as the cargo receptor mediating Nature. 2014 Mar 30. ferritinophagy.

PAF1 Adenovirus E1A recruits the hPaf1 complex to enhance transcriptional elongation. J Virol. 2014 Mar 5.

POLR2A Transcriptional Amplification in Tumor Cells with Elevated c-Myc. Cell. 2012 Sep 28;151(1):56-67.

REST REST and stress resistance in ageing and Alzheimer’s disease Nature. 2014 Mar 27;507(7493):448- 54.

SALL2 Reconstructing and Reprogramming the Tumor-Propagating Potential of Cell. 2014 Apr 9. pii: S0092- Glioblastoma Stem-like Cells. 8674(14)00229-3.

SIRT1 DBIRD complex integrates alternative mRNA splicing with RNA polymerase II Nature. 2012 Mar 25;484(7394):386- transcript elongation. 9.

SUZ12 A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 2014 Aug 10.

TOP1 Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative Nat Neurosci. 2014 May 4. genome instability syndromes.

TP53BP1 MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature. 2014 Apr 10;508(7495):215- 21.

TRIM28 / KAP-1 DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier. Nature. 2014 Jul 27.

TRIM28 / KAP-1 Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative Nat Neurosci. 2014 May 4. genome instability syndromes.

UBE3A Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature. 2014 Dec 1.

USP7 UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription- Nat Genet. 2012;44(5):598-602. coupled repair.

P.O. Box 850 | Montgomery, Texas 77356 | 800.338.9579 | bethyl.com